Brunswick director Singer receives 1,097-share grant
Of the award, 458 shares are deferred and will be automatically distributed in predetermined installments after David V. Singer ceases to be a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Brunswick Corp. (BC) director David V. Singer acquired 1,097 common shares in a grant/award on October 30, 2026; the reported per-share amount was $75.34. Of those shares, 458 are deferred and will be automatically distributed in predetermined installments after he ceases to be a director. His direct holdings following the transaction were 38,817 shares, and his indirect holdings through the Barbara B Singer 2014 Irrevocable Trust were 19,789 shares. The disclosed beneficial holdings include 174 shares acquired through dividend reinvestment through September 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 1,097 | $75.34 | $83K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. 458 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
- F2. Beneficial holdings include 174 shares acquired pursuant to dividend reinvestment through September 2026.
Key Figures
Key Terms
director's deferred account financial
dividend reinvestment financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.